Review Article
Efficacy and Safety of Aidi Injection as an Adjuvant Therapy on Advanced Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Figure 6
ADI decreased the numbers of myelosuppression in BC patients as an add-on therapy (RR = 0.69; 95% CI 0.52–0.92; I2 = 72%; ).